11-17531234-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 5P and 13B. PM1PM5PP3BP4_StrongBP6BS1BS2

The NM_153676.4(USH1C):​c.307C>T​(p.Arg103Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00053 in 1,614,136 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R103H) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00056 ( 7 hom. )

Consequence

USH1C
NM_153676.4 missense

Scores

8
5
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 4.76

Publications

2 publications found
Variant links:
Genes affected
USH1C (HGNC:12597): (USH1 protein network component harmonin) This gene encodes a scaffold protein that functions in the assembly of Usher protein complexes. The protein contains PDZ domains, a coiled-coil region with a bipartite nuclear localization signal and a PEST degradation sequence. Defects in this gene are the cause of Usher syndrome type 1C and non-syndromic sensorineural deafness autosomal recessive type 18. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
USH1C Gene-Disease associations (from GenCC):
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • autosomal recessive nonsyndromic hearing loss 18A
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 7 uncertain in NM_153676.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-17531233-C-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 39427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
Multiple lines of computational evidence support a deleterious effect 9: AlphaMissense, Cadd, Dann, FATHMM_MKL, M_CAP, PrimateAI, PROVEAN, REVEL, REVEL [when BayesDel_addAF, max_spliceai, MetaRNN, MutationAssessor, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.022108346).
BP6
Variant 11-17531234-G-A is Benign according to our data. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013. Variant chr11-17531234-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 48013.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00021 (32/152298) while in subpopulation SAS AF = 0.00643 (31/4818). AF 95% confidence interval is 0.00466. There are 0 homozygotes in GnomAd4. There are 30 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 7 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH1CNM_153676.4 linkc.307C>T p.Arg103Cys missense_variant Exon 4 of 27 ENST00000005226.12 NP_710142.1 Q9Y6N9-5
USH1CNM_005709.4 linkc.307C>T p.Arg103Cys missense_variant Exon 4 of 21 ENST00000318024.9 NP_005700.2 Q9Y6N9-1A0A0S2Z4U9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH1CENST00000005226.12 linkc.307C>T p.Arg103Cys missense_variant Exon 4 of 27 5 NM_153676.4 ENSP00000005226.7 Q9Y6N9-5
USH1CENST00000318024.9 linkc.307C>T p.Arg103Cys missense_variant Exon 4 of 21 1 NM_005709.4 ENSP00000317018.4 Q9Y6N9-1

Frequencies

GnomAD3 genomes
AF:
0.000210
AC:
32
AN:
152180
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00643
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00105
AC:
263
AN:
251126
AF XY:
0.00130
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000564
AC:
824
AN:
1461838
Hom.:
7
Cov.:
31
AF XY:
0.000752
AC XY:
547
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00785
AC:
677
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53364
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000101
AC:
112
AN:
1112012
Other (OTH)
AF:
0.000530
AC:
32
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000210
AC:
32
AN:
152298
Hom.:
0
Cov.:
33
AF XY:
0.000403
AC XY:
30
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41570
American (AMR)
AF:
0.00
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00643
AC:
31
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000908
Hom.:
0
Bravo
AF:
0.0000453
ExAC
AF:
0.000997
AC:
121
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Mar 02, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The USH1C c.307C>T; p.Arg103Cys variant (rs397517880) has been reported in the heterozygous state in a single individual diagnosed with Usher Syndrome type I (Besnard 2014). Another variant affecting this codon, Arg103His, has also been reported in two individuals with Usher Syndrome (Roux 2006, Saihan 2011). However, this variant is listed in the genome Aggregation Database (gnomAD) with a South Asian population frequency of 0.8% (identified on 261 out of 30,776 chromosomes, including 3 homozygotes) and is classified as a variant of uncertain significance in ClinVar (ID: 48013). The arginine at position 103 is highly conserved, considering 12 species, and computational analyses of the effects of the p.Arg103Cys variant on protein structure and function predict a deleterious effect (SIFT: damaging, PolyPhen-2: probably damaging). Based on the available information, the clinical significance of the p.Arg103Cys variant cannot be determined with certainty. -

Jul 15, 2019
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 05, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32467589, 30245029, 24498627) -

not specified Uncertain:1
Sep 04, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Pathogenic. The Arg103Cys v ariant in USH1C has been reported in one French individual with Usher syndrome t ype I (Besnard 2014) and has been identified in one Indian individual with senso rineural hearing loss by our laboratory (LMM unpublished data); however a second variant in USH1C was not detected in either individual. This variant is absent from large population studies. Another amino acid change at this position (Arg10 3His) has been identified in two individuals with Usher syndrome who were compou nd heterozygous with another pathogenic USH1C (Roux 2006, Saihan 2011), and the variant segregated with disease in an affected sibling of one of those individua ls (Saihain 2011). These data suggest that variants that alter the arginine resi due at position 103 may not be tolerated. Computational prediction tools and con servation analyses suggest that the Arg103Cys variant may impact the protein, th ough this information is not predictive enough to determine pathogenicity. In su mmary, while there is some suspicion for a pathogenic role, the clinical signifi cance of the Arg103Cys variant is uncertain. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.77
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.060
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.27
T;.;.;.;T
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.97
D;D;D;D;D
M_CAP
Pathogenic
0.41
D
MetaRNN
Benign
0.022
T;T;T;T;T
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
1.2
L;.;L;L;.
PhyloP100
4.8
PrimateAI
Pathogenic
0.85
D
PROVEAN
Pathogenic
-7.4
D;D;D;D;D
REVEL
Pathogenic
0.83
Sift
Pathogenic
0.0
D;D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;.
Polyphen
1.0
D;.;D;.;.
Vest4
0.96
MutPred
0.78
Loss of methylation at R103 (P = 0.0217);.;Loss of methylation at R103 (P = 0.0217);Loss of methylation at R103 (P = 0.0217);.;
MVP
0.62
MPC
0.45
ClinPred
0.17
T
GERP RS
4.5
Varity_R
0.91
gMVP
0.77
Mutation Taster
=34/66
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397517880; hg19: chr11-17552781; COSMIC: COSV99140619; API